Prevention of venous thromboembolism after total hip and knee arthroplasty.
Lieberman
J R
JR
Department of Orthopaedic Surgery, University of California at Los Angeles School of Medicine 90024.
Geerts
W H
WH
D000758:Anesthesia; D003362:Cost-Benefit Analysis; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006622:Hip Prosthesis / Q000009:adverse effects; D006801:Humans; D007720:Knee Prosthesis / Q000009:adverse effects; D011183:Postoperative Complications / Q000517:prevention & control*; D013923:Thromboembolism / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D015912:Thrombolytic Therapy / Q000191:economics; D014859:Warfarin / Q000627:therapeutic use
D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin; D006493:Heparin